Matinas BioPharma
(NYSEMKT) MTNB
Matinas BioPharma Financials at a Glance
Market Cap
$4.10M
Revenue (TTM)
$0.00
Net Income (TTM)
$17.48M
EPS (TTM)
$-3.41
P/E Ratio
-0.19
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$0.63
Volume
13,814.462
Open
$0.66
Price
$0.63
Volume
13,814.462
Open
$0.66
Previous Close
$0.64
Daily Range
$0.60 - $0.66
52-Week Range
$0.47 - $3.09
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$0.63
Volume
13,814.462
Open
$0.66
Previous Close
$0.64
Daily Range
$0.60 - $0.66
52-Week Range
$0.47 - $3.09
MTNB News
MTNB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Matinas BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Jerome D. Jabbour
Website
www.matinasbiopharma.comHeadquarters
Bedminster, NJ 07921, US
MTNB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-157%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-5.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.10M
Shares Outstanding
6.41M
Volume
13.81K
Short Interest
0.00%
Avg. Volume
29.66K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$24.59M
EBITDA
$19.19M
Operating Cash Flow
$15.88M
Capital Expenditure
$0.00
Free Cash Flow
$15.88M
Cash & ST Invst.
$7.28M
Total Debt
$2.89M
Matinas BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$4.10M
N/A
Market Cap/Employee
$1.37M
N/A
Employees
3
N/A
Net Income
$2.15M
+49.7%
EBITDA
$2.04M
+52.5%
Quarterly Fundamentals
Net Cash
$3.10M
-59.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.48M
-36.4%
Short Term Debt
$851.00K
+15.3%
Return on Assets
-1.80%
N/A
Return on Invested Capital
-1.69%
N/A
Free Cash Flow
$1.47M
+57.9%
Operating Cash Flow
$1.47M
+57.9%